Liver damage, relationship to multiple damage of organs failure in 1143 died by sepsis
Keywords:
sepsis, multiple organ failure, liver failureAbstract
Alterations in immune regulation in the liver and digestive tract predispose to multiple damage of organs and hinder its resolution. The clinical appearance of hepatic dysfunction may be delayed with respect to the beginning of sepsis, worsen the clinical course of the patient and promoting the emergence of multiple damage of organs. 1143 autopsies of deceased were analyzed with sepsis -the Automated System for Registration and Control of pathologically Anatomy was used- and it is emphasized in the histological diagnosis of the liver, in which the most obvious structural alterations were reactive hepatitis, hepatic steatosis and hepatic cholestasis, always related to sepsis. The relationship of these structural patterns of the liver of patients with severe sepsis and multiple damage of organs were checked. All who developed multiple damage of organs presented reactive hepatitis, 39.62% of patients with hepatic steatosis and 33.33% of patients with hepatic cholestasis developed multiple damage of organs.Downloads
References
1. Hernández-Palazón J, Fuentes-García D, Burguillos-López S, Doménech-Asensi P, Sansano-Sánchez TV, Acosta-Villegas F. Análisis de la insuficiencia de órganos y mortalidad en la sepsis por peritonitis secundaria. Med Intensiva [Internet]. 2013 [citado 12 Abr 2014];37(7):461-7. Disponible en: http://www.medintensiva.org/es/analisis-insuficiencia-organos-mortalidad-sepsis/articulo/S0210569112002501/
2. Ramírez M. Multiple organ dysfunction syndrome. Curr Probl Pediatr Adolesc Health Care [Internet]. 2013 [citado 20 Abr 2014];43(10):273-277. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24295608
3. Kandil SB, Miksa M, Faustino EV. Control of serum glucose concentration in critical illness. Curr Opin Pediatr [Internet]. 2013 [citado 29 May 2014];25(3):297-303. Disponible en: http://journals.lww.com/copediatrics/Abstract/2013/06000/Control_of_serum_glucose_concentration_in_critical.4.aspx?trendmd-shared=0
4. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med [Internet]. 2013 [citado 12 Abr 2014];41(2):461-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23353941
5. Azkárate I, Sebastián R, Cabarcos E, Choperena G, Pascal M, Salas E. Registro observacional y prospectivo de sepsis grave/shock séptico en un hospital terciario de la provincia de Guipúzcoa. Med Intensiva [Internet]. 2012 [citado 12 Abr 2014];41(2):[aprox. 11 p.]. Disponible en: http://scielo.isciii.es/scielo.php?pid=S0210-56912012000400003&script=sci_arttext
6. Aronsohn A, Jensen D. Hepatobiliary manifestations of critically ill and postoperative patients. Clin Liver Dis [Internet]. 2011 [citado 12 Jul 2014];15(1):183-97. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21112000
7. Suberviola B, Castellanos-Ortega A, Ruiz Ruiz A, Lopez-Hoyos M, Santibañez M. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Med [Internet]. 2013 [citado 12 Abr 2014];39(11):1945-52. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23949703
8. Angus DC, Van der Poll T. Severe sepsis and septic shock. N Engl J Med [Internet]. 2013 [citado 12 Jun 2014];369:840-51. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMar1208623
9. Boyer TD, Manns MP, Sanyal AJ. Zakim and Boyer’s hepatology: a textbook of liver disease. 6th ed. Philadelphia, PA: Saunders/Elsevier; 2012.
10. Cabrera Rosell P, Montero González T, Hurtado de Mendoza Amat J, Pérez Bomboust I, Cabrejas Acuña MO, McCook Noa L, et al. Utilidad de un sistema de puntuación para el diagnóstico del daño múltiple de órganos. Rev Cub Med Mil [Internet]. 2003 [citado 12 Abr 2014]; 32(1):24-31. Disponible en: http://scielo.sld.cu/pdf/mil/v32n1/mil04103.pdf
11. Montero González T, Hurtado de Mendoza Amat J, Iglesias Duquesne M, Walwyn Salas V, Cabrejas Acuña MO, Pérez Bomboust I. Factores causales del daño múltiple de órganos en 11 307 autopsias realizadas en el Instituto Superior de Medicina Militar “Dr. Luis Díaz Soto” Rev Cub Med Mil [Internet]. 2008 [citado 12 Abr 2014];37(1):[aprox. 9 p.]. Disponible en: http://scielo.sld.cu/pdf/mil/v37n1/mil07108.pdf
12. Vassiliadis T, Mpoumponaris A, Vakalopoulou S, Giouleme O, Gkissakis D, Grammatikos N, et al. Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: incidence and correlation with disease severity and survival. Hepatol Res [Internet]. 2010 [citado 12 Abr 2014];40(2):161-70. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20070401
13. Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. Br J Haematol [Internet]. 2010 [citado 21 Abr 2014];148(4):507-21. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19995396
14. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood [Internet]. 2010 [citado 12 Abr 2014]; 116(6):878-85. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20400681
15. Albayrak A, Uyanik MH, Odabasoglu F, Halici Z, Uyanik A, Bayir Y, et al. The effects of diabetes and/or polymicrobial sepsis on the status of antioxidant enzymes and pro-inflammatory cytokines on heart, liver, and lung of ovariectomized rats. J Surg Res
[Internet]. 2011 [citado 12 Abr 2014];169(1):67-75. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20080253
16. Stravitz RT, Kramer DJ. Acute liver failure. En: Boyer TD, Manns MP, Sanyal AJ. Zakim and Boyer’s hepatology: a textbook of liver disease. 6th ed. Philadelphia, PA: Saunders/Elsevier; 2012. p. 327-351.
17. Strassburg CP, Manns MP. Liver biopsy (Quality and Use of Gun). En: Boyer TD, Manns MP, Sanyal AJ. Zakim and Boyer’s hepatology: a textbook of liver disease. 6th ed. Philadelphia, PA: Saunders/Elsevier; 2012. p. 173-183.
18. Brunt EM. Liver biopsy interpretation. En: Boyer TD, Manns MP, Sanyal AJ. Zakim and Boyer’s hepatology: a textbook of liver disease. 6th ed. Philadelphia, PA: Saunders/Elsevier; 2012. p. 185-200.
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).